Catalyst Wire Dossier Catalyst Wire Dossier

Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells

mesenchymal stem cells
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells, covering 2017-08-10 to 2017-08-10. Get the full timeline:

Most recent: Clinical Trial Update: Feasibility Study of Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in Patients With Multiple Sclerosis [Phase 1, Phase 2]

See pricing